Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Todd DeVries

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Pharmaceutical Statistics|April 3, 2024
A practical guide to the appropriate analysis of eGFR data over time: A simulation studyTodd DeVries, Kevin J Carroll, Sandra A Lewis
Pharmaceutical Statistics|November 3, 2023
Conditional power and information fraction calculations at an interim analysis for random coefficient modelsSandra A Lewis, Kevin J Carroll, Todd DeVries, et al.
Journal of the American Academy of Dermatology|December 31, 2003
Medical and dermatology dictionaries: an examination of unstructured definitions and a proposal for the futureDavid Todd DeVries, Art Papier, Jennifer Byrnes, et al.
British Journal of Clinical Pharmacology|September 26, 2006
Pharmacokinetics of subcutaneously administered etanercept in subjects with psoriasisIvan Nestorov, Ralph Zitnik, Todd DeVries, et al.
Cancer Immunology Research|May 7, 2015
Survival Outcomes of Sipuleucel-T Phase III Studies: Impact of Control-Arm Cross-Over to Salvage ImmunotherapyDaniel J George, Chadi Nabhan, Todd DeVries, et al.
Cancer Research|May 25, 2016
Clonotypic Diversification of Intratumoral T Cells Following Sipuleucel-T Treatment in Prostate Cancer SubjectsNadeem Sheikh, Jason Cham, Li Zhang, et al.
Arthritis and Rheumatism|February 12, 2004
Once-weekly administration of 50 mg etanercept in patients with active rheumatoid arthritis: results of a multicenter, randomized, double-blind, placebo-controlled trialEdward C Keystone, Michael H Schiff, Joel M Kremer, et al.
Cancer Immunology Research|September 6, 2014
A transient increase in eosinophils is associated with prolonged survival in men with metastatic castration-resistant prostate cancer who receive sipuleucel-TDouglas G McNeel, Thomas A Gardner, Celestia S Higano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2008
Phase I clinical study of atacicept in patients with relapsed and refractory B-cell non-Hodgkin's lymphomaStephen M Ansell, Thomas E Witzig, David J Inwards, et al.
Clinical Genitourinary Cancer|December 3, 2014
Combining immunotherapy and radiation for prostate cancerSteven E Finkelstein, Sharon Salenius, Constantine A Mantz, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Pharmaceutical Statistics|April 3, 2024
A practical guide to the appropriate analysis of eGFR data over time: A simulation studyTodd DeVries, Kevin J Carroll, Sandra A Lewis
Pharmaceutical Statistics|November 3, 2023
Conditional power and information fraction calculations at an interim analysis for random coefficient modelsSandra A Lewis, Kevin J Carroll, Todd DeVries, et al.
Journal of the American Academy of Dermatology|December 31, 2003
Medical and dermatology dictionaries: an examination of unstructured definitions and a proposal for the futureDavid Todd DeVries, Art Papier, Jennifer Byrnes, et al.
British Journal of Clinical Pharmacology|September 26, 2006
Pharmacokinetics of subcutaneously administered etanercept in subjects with psoriasisIvan Nestorov, Ralph Zitnik, Todd DeVries, et al.
Cancer Immunology Research|May 7, 2015
Survival Outcomes of Sipuleucel-T Phase III Studies: Impact of Control-Arm Cross-Over to Salvage ImmunotherapyDaniel J George, Chadi Nabhan, Todd DeVries, et al.
Cancer Research|May 25, 2016
Clonotypic Diversification of Intratumoral T Cells Following Sipuleucel-T Treatment in Prostate Cancer SubjectsNadeem Sheikh, Jason Cham, Li Zhang, et al.
Arthritis and Rheumatism|February 12, 2004
Once-weekly administration of 50 mg etanercept in patients with active rheumatoid arthritis: results of a multicenter, randomized, double-blind, placebo-controlled trialEdward C Keystone, Michael H Schiff, Joel M Kremer, et al.
Cancer Immunology Research|September 6, 2014
A transient increase in eosinophils is associated with prolonged survival in men with metastatic castration-resistant prostate cancer who receive sipuleucel-TDouglas G McNeel, Thomas A Gardner, Celestia S Higano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2008
Phase I clinical study of atacicept in patients with relapsed and refractory B-cell non-Hodgkin's lymphomaStephen M Ansell, Thomas E Witzig, David J Inwards, et al.
Clinical Genitourinary Cancer|December 3, 2014
Combining immunotherapy and radiation for prostate cancerSteven E Finkelstein, Sharon Salenius, Constantine A Mantz, et al.
Pageof 2